Huma to provide best-in-class digital clinical trials solutions through landmark acquisition of Alcedis
Comment
Preventing Cervical Cancer with Digital Health
June 28, 2023
Comment
Preventing Cervical Cancer with Digital Health
June 28, 2023
Share this
This is some text inside of a div block.
mins read
In England alone, around 2,700 women are diagnosed with cervical cancer each year. However, the NHS screening programme saves approximately 5,000 lives annually. Sadly, 850 women still lose their lives to cervical cancer every year. 83% of these deaths could be avoidable if all eligible women participated in their screenings, potentially saving 706 lives.
Screening programmes play a pivotal role in early detection and prevention of cervical cancer. By employing highly effective tests to check for high-risk human papillomavirus (HPV), which is found in over 99% of all cervical cancers, screenings can identify abnormal cells in the cervix. These abnormal cells, if left untreated, can develop into cancer over time.
Through [the project commissioned by NHS England and North of England CSU], attendance rates for cervical cancer screenings increased by 6.3% in London. The project reduced the invite-to-appointment time by 17 days.
Increasing screening attendance with digital health technology
One remarkable success story in promoting cervical cancer screenings is the project commissioned by NHS England and North of England CSU. The project used iPLATO's Population Health Service to send text message reminders to women who were due for their screening appointment. Through this initiative, attendance rates for cervical cancer screenings increased by 6.3% in London. The project reduced the invite-to-appointment time by 17 days. We are proud that iPLATO, part of the Huma family, was nominated for the 2023 HSJ Digital Awards for this exceptional work.
Saving costs for the NHS
The financial and human impact of cervical cancer cannot be ignored. The average cost to the NHS for treating an individual diagnosed with stage 2 cervical cancer or later is £19,261. In contrast, for those diagnosed at stage 1a, the cost drops significantly to around £1,379 per person. By implementing simple interventions such as text message reminders, we can bridge the gap between individuals receiving timely treatment and the NHS saving thousands of pounds in treating patients with late-stage cervical cancer.
Seamless connectivity and efficient healthcare
At Huma, our vision encompasses a healthcare system where an individual’s health and social care information is seamlessly connected and easily navigable. By enabling clinicians and care providers to access a complete picture of a person's health history, we can efficiently manage population health using valuable data. Through the integration of digital health technologies, we can create a future where preventive care and early detection are prioritised, leading to better health outcomes for all.
Screening is a powerful tool in preventing cervical and other cancers. By leveraging digital health solutions and innovative projects like those supported by iPLATO, we can significantly increase screening attendance rates and save lives. Let's continue to raise awareness, use technology for good, and create a connected healthcare system that prioritises preventive care. Together, we can transform cervical cancer prevention and ensure a healthier future for women all over the world.
Contact us to discover more
One of our team members will be in touch with you shortly.
Oops! Something went wrong while submitting the form.
You will receive an email from us shortly containing the file. Please check your inbox (and promotions tab or spam folder, if necessary) for the email.
Oops! Something went wrong while submitting the form
Subscribe
Get Huma's latest releases in your inbox.
One of our team members will be in touch with you shortly.
Oops! Something went wrong while submitting the form.
One of our team members will be in touch with you shortly.
Oops! Something went wrong while submitting the form.
Making an impact
3000+
3000+ hospitals and clinics supported across Huma platforms to secure the most sustainable impact for patients1
×2
Our platform can almost double clinical capacity and reduce readmission rates by >30%3
27m+
Huma's digital-first health platforms support a network of 27m patients1
1m+
Over 1 million devices have been shipped in support of our projects and we know what it takes to deploy at scale1
Winner of the 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'4
Selected as one of 'The Most Important Healthcare Design of 2021' by Fast Company5
Winner of the 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'4
Winner of the 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'4
Huma joins digital pioneers to advance health equity in care and research
Chief Executive Officer and Founder, Dan Vahdat, is returning to the annual World Economic Forum’s main conference where he will join a panel discussion devoted to improving care for non-communicable disease and tackling health equity. Accompanied by Chief Financial and Strategy Officer, Ingeborg Oie, Dan is looking forward to connecting with other attendees to explore how Huma’s digital health platform can make healthcare more equitable, and advances proactive, predictive care.
Huma joins digital pioneers to advance health equity in care and research
Date:Wednesday, January 18, 2023
Time:4:15 - 5:15 p.m. CET
Location:Ice Village, Eisbahnstrasse 5, Davos, Switzerland
Dan will join the Digital Health Action Alliance panel at Davos to discuss Turning the Tide in Non-Communicable Disease Care Through Digital Health and Community Connection. Huma has a long history of advancing the care of non-communicable diseases (NCDs) such as heart disease, cancer, diabetes and lung conditions. Huma’s innovative remote patient monitoring platform enables broad patient recruitment, reduces reliance on in-person clinic visits and increases health system efficiency.
*This session is open to registered Annual Meeting 2023 participants and Affiliate badge holders.
Huma is one of the first to sign the Zero Health Gaps Pledge
Huma is one of the first signatories to the Zero Health Gaps Pledge, the World Economic Forum’s Global Health Equity Network’s (GHEN) initiative. Huma supports GHEN’s ambition to build a future without disparities in health or wellbeing outcomes. Huma’s digital platform has been built on a deep clinical knowledge of complex patient needs and how people engage with technology and we are committed to ensuring our technology promotes health equity. We are proud to work with governments, hospital groups, universities, life science and technology companies to bring greater scale and impact and help all people live longer, fuller lives.
In England alone, around 2,700 women are diagnosed with cervical cancer each year. However, the NHS screening programme saves approximately 5,000 lives annually. Sadly, 850 women still lose their lives to cervical cancer every year. 83% of these deaths could be avoidable if all eligible women participated in their screenings, potentially saving 706 lives.
Screening programmes play a pivotal role in early detection and prevention of cervical cancer. By employing highly effective tests to check for high-risk human papillomavirus (HPV), which is found in over 99% of all cervical cancers, screenings can identify abnormal cells in the cervix. These abnormal cells, if left untreated, can develop into cancer over time.
asdasd
asda
asdsads
asda
asdsad
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
One of our team members will be in touch with you shortly.
Oops! Something went wrong while submitting the form.
COMPANY
About Huma
Huma began its journey in 2011, when the company was founded in London. Since then, Huma has grown to become a global healthcare company, spanning across multiple geographies and operating across four continents.
By clicking “Accept All”, you consent to our website’s use of cookies to make our site function and give you a better experience by remembering your preferences, repeat visits and making site improvements. However, you may visit “Manage Cookies” to manage your preferences. Read more about our cookie policy